These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36304987)

  • 1. Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis.
    Wang DD; Xu WX; Chen WQ; Li L; Yang SJ; Zhang J; Tang JH
    J Oncol; 2022; 2022():9133636. PubMed ID: 36304987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
    Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
    Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer.
    Zhang H; Ding C; Li Y; Xing C; Wang S; Yu Z; Chen L; Li P; Dai M
    Bioengineered; 2021 Dec; 12(1):3634-3646. PubMed ID: 34252356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
    Chen WQ; Yang SJ; Xu WX; Deng F; Wang DD; Tang JH
    Medicine (Baltimore); 2021 Oct; 100(42):e27489. PubMed ID: 34678879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
    Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W
    Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
    Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
    Front Oncol; 2021; 11():607224. PubMed ID: 34026603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment.
    Xu WX; Zhang J; Hua YT; Yang SJ; Wang DD; Tang JH
    Front Oncol; 2020; 10():605097. PubMed ID: 33425761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
    Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
    Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer.
    Chen J; Gao G; Li L; Ding J; Chen X; Lei J; Long H; Wu L; Long X; He L; Shen Y; Yang J; Lu Y; Sun Y
    Front Genet; 2022; 13():817118. PubMed ID: 35601500
    [No Abstract]   [Full Text] [Related]  

  • 11. Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics.
    Wei R; Rodrìguez RA; Mullor MDMR; Tan Z; Gui Y; Hu J; Zhu T; Huang X; Zhu Y; Xu J
    Ann Transl Med; 2020 Apr; 8(8):552. PubMed ID: 32411775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-cancer analysis.
    Liao X; Wang W; Yu B; Tan S
    Cancer Cell Int; 2022 Jun; 22(1):213. PubMed ID: 35701829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
    Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RecQ mediated genome instability 2 (
    Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
    Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
    Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
    Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer.
    Lv Z; Qi L; Hu X; Mo M; Jiang H; Fan B; Li Y
    Front Mol Biosci; 2021; 8():631067. PubMed ID: 33665207
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.